Advanced Body Composition Bundle
Original price was: $318.00.$225.00Current price is: $225.00.
- Description
- 3rd Party Lab Testing
Description
Product Overview
The Reta GLP-3 + CJC-1295 No DAC + Ipamorelin bundle combines three advanced research peptides designed to model multi-hormonal pathways governing metabolism, growth hormone (GH) secretion, and body composition regulation.
-
Retatrutide (Reta-GLP-3) acts as a triple receptor agonist (GLP-1, GIP, and glucagon), supporting research on blood sugar balance, lipid metabolism, and appetite control.
-
CJC-1295 No DAC, a growth hormone–releasing hormone (GHRH) analog, promotes transient GH pulses and IGF-1 activity while preserving natural endocrine feedback mechanisms.
-
Ipamorelin, a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist, enhances GH signaling specificity and enables studies of anabolic recovery without affecting cortisol or prolactin levels.
Together, these peptides create a triple-pathway research model exploring incretin, pituitary, and ghrelin receptor signaling — ideal for studies on fat metabolism, energy expenditure, lean muscle maintenance, and endocrine coordination.
Technical Specifications
Retatrutide (Reta-GLP-3): 12mg lyophilized peptide vial
CJC-1295 No DAC: 10mg lyophilized peptide vial
Ipamorelin: 10mg lyophilized peptide vial
Purity: >99% (HPLC-tested)
Form: Lyophilized powder
Storage: Stable at room temperature before reconstitution; refrigerate after reconstitution
Why Choose BioEdge Research Labs Reta GLP-3 + CJC-1295 No DAC + Ipamorelin bundle?
-
Research-grade purity verified at >99% through third-party testing.
-
Sterile, tamper-resistant packaging designed for compound integrity.
-
Most orders ship within 24 hours of payment confirmation from our U.S.-based facility.
-
Dedicated customer support for researchers.
Summary of Preclinical Research Findings
Metabolic Regulation & Incretin-GH Synergy
Retatrutide’s triple receptor activation supports the study of glucose control and fat oxidation, while CJC-1295 and Ipamorelin enhance GH and IGF-1 activity. This blend allows researchers to examine how incretin-based and GH-mediated mechanisms jointly affect metabolic rate, fat utilization, and insulin sensitivity.
Growth Hormone Pulsatility & Endocrine Function
CJC-1295 No DAC induces controlled GH pulses, while Ipamorelin triggers selective GH release via ghrelin receptor activation. Together, they provide an adaptable model for studying short-acting hormone dynamics, pituitary feedback regulation, and natural rhythm preservation.
Anabolic Support & Tissue Regeneration
Ipamorelin’s influence on GH and IGF-1 complements CJC-1295’s anabolic signaling, forming a strong base for muscle recovery, cellular repair, and bone turnover studies. In combination with Retatrutide’s metabolic effects, the trio supports exploration of lean tissue preservation during energy restriction.
Fat Metabolism & Body Composition
Retatrutide’s thermogenic and fat oxidation properties align with GH-driven lipolysis from CJC-1295 and Ipamorelin, producing a synergistic model for visceral fat redistribution, lipid metabolism, and caloric efficiency.
Hormonal Crosstalk & Aging Research
This combination facilitates investigation into the relationship between incretin signaling, ghrelin activity, and GHRH function. Researchers can explore the integration of these systems in models of endocrine decline, metabolic aging, and regenerative balance.
Suggested Research Applications
-
Triple-pathway analysis of metabolic and endocrine coordination
-
Studies on GH/IGF-1 synergy in fat loss and tissue recovery
-
Incretin and ghrelin receptor interaction modeling
-
Metabolic aging and anti-catabolic research models
-
GH pulsatility and pituitary feedback investigations
-
Muscle regeneration and bone turnover studies
-
Energy balance and thermogenic pathway assessment
For Research Use Only
The Reta GLP-3 12mg + CJC-1295 No DAC 10mg + Ipamorelin 10mg bundle is supplied by BioEdge Research Labs exclusively for laboratory and in vitro research.
-
Not for human or animal use
-
Not for medical or diagnostic purposes
-
Purchase confirms that the buyer is a qualified researcher, 18 years or older
-
All research use must comply with local and institutional regulations
Summary of References
Retatrutide in Metabolic and Fat-Loss Research
-
Jastreboff, A. M., et al. (2023). Triple-hormone receptor agonist Retatrutide supports significant weight loss in obesity models. New England Journal of Medicine, 389(1), 11–22. https://www.nejm.org/doi/abs/10.1056/NEJMoa2301972
-
Lin, Y., et al. (2024). Retatrutide and fat distribution in metabolic obesity models. Nature Medicine, 30(4), 511–520. https://www.nature.com/articles/s41591-024-03018-2
-
Wharton, S., et al. (2023). Body weight outcomes in patients receiving Retatrutide: Phase 2 findings. The Lancet, 402(10397), 9–20. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01053-X/abstract
CJC-1295 No DAC in GH and Regeneration Research
-
Lapira, J., et al. (2008). Age-related GHRH signaling and GH pulsatility. Journal of Neuroendocrinology, 20(9), 1012–1019. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2826.2008.01740.x
-
Mieritz, M. G., et al. (2009). Body composition and metabolic outcomes after GH analog administration. Hormone Research in Paediatrics, 72(2), 114–122. https://www.sciencedirect.com/science/article/pii/S1096637409000409
-
Bridon, D. P., et al. (2004). CJC-1295 as a long-acting GHRH analog with regenerative implications. ResearchGate. https://www.researchgate.net/publication/26667105_CJC-1295_as_a_long-acting_GHRH_analog_with_regenerative_implications
Ipamorelin in GH Secretion and Tissue Regeneration Research
-
Thorner, M. O., Vance, M. L., Kaiser, D. L., & Jaffe, C. A. (1998). Growth hormone-releasing peptide-2 stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology & Metabolism, 83(2), 876–882. https://www.ncbi.nlm.nih.gov/pubmed/9849822
-
Chang, J. P., et al. (2016). GHSR1a signaling: Molecular determinants and role in growth hormone secretion and energy balance. Frontiers in Endocrinology, 7, 212. https://www.ncbi.nlm.nih.gov/pubmed/27186127
-
Elsaid, M., et al. (2018). Growth hormone secretagogues promote muscle regeneration in sarcopenia models. Journal of Cachexia, Sarcopenia and Muscle, 9(5), 918–926. https://pubmed.ncbi.nlm.nih.gov/30168238/
BioEdge Research Labs
Precision. Purity. Performance.
At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.










